OpenVSafe by OpenVAERS
Search V-safe

XXH-70997-89611

2 vaccinations 2 coded responses 17 check-ins 2 free-text entries 1 call case
Sex
Male
Age at first dose
0-4
ZIP prefix
074 / NJ
Registered
2022-07-01
Relationship
Child or adolescent in my care
Guardian
RJB-13627-80746
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-06-30
    Dose 1 — Pfizer-BioNTech
  2. 2022-07-01
    Registered in v-safe
  3. 2022-07-01
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-07-02
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-07-03
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-07-04
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-07-05
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-07-06
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2022-07-07
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2022-07-14
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  11. 2022-07-21
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-07-26
    Dose 2 — Pfizer-BioNTech
  13. 2022-07-27
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  14. 2022-07-28
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Fever · None
    Under 3 check-in
  15. 2022-07-29
    Survey response — days 1–6 daily, dose 2, under 3
    MedDRA: Dysphonia — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Hoarseness
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-07-29
    Report sent to call center — days 1–6 daily, dose 2, under 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  17. 2022-07-30
    Survey response — days 1–6 daily, dose 2, under 3
    MedDRA: Dysphonia — Feeling: Fair
    Free text: Hoarseness
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-08-01
  19. 2022-08-01
    Call successful
    Participant prefers to complete VAERS report online
  20. 2022-08-16
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  21. 2022-08-23
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  22. 2022-08-30
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  23. 2022-09-06
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-06-30Pfizer-BioNTech No
22022-07-26Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 12 (Under 3) — days 1–6 daily, dose 2, under 3

2022-07-29

Systemic reaction (other): Hoarseness

2022-07-30

Systemic reaction (other): Hoarseness

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SRODysphonia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release